David I Marks

Summary

Country: UK

Publications

  1. doi request reprint Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors
    David I Marks
    Haematologica 99:322-8. 2014
  2. pmc The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial
    David I Marks
    Adult BMT Unit, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
    Haematologica 98:945-52. 2013
  3. doi request reprint Treating the "older" adult with acute lymphoblastic leukemia
    David I Marks
    Haematology and Stem Cell Transplantation, Bristol BMT Unit, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
    Hematology Am Soc Hematol Educ Program 2010:13-20. 2010
  4. pmc Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
    David I Marks
    University Hospitals Bristol NHS Foundation Trust, Bristol, UK
    Br J Haematol 155:318-27. 2011
  5. ncbi request reprint Haploidentical stem cell transplantation for children with acute leukaemia
    David I Marks
    BMT Unit, Bristol Children s Hospital, United Bristol Healthcare Trust, Bristol, UK
    Br J Haematol 134:196-201. 2006
  6. ncbi request reprint A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission
    David I Marks
    Adult BMT Unit, Bristol Children s Hospital, Bristol, UK
    Biol Blood Marrow Transplant 12:438-53. 2006

Detail Information

Publications6

  1. doi request reprint Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors
    David I Marks
    Haematologica 99:322-8. 2014
    ....
  2. pmc The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial
    David I Marks
    Adult BMT Unit, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
    Haematologica 98:945-52. 2013
    ..Prospective trials are required to determine whether poor outcomes in older patients can be improved by reduced-intensity conditioning allografts. NCT00002514 www.clinicaltrials.gov...
  3. doi request reprint Treating the "older" adult with acute lymphoblastic leukemia
    David I Marks
    Haematology and Stem Cell Transplantation, Bristol BMT Unit, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
    Hematology Am Soc Hematol Educ Program 2010:13-20. 2010
    ..A better understanding of the biology of the disease (including gene profiling) may allow individualization of therapy and, in time, targeted therapy...
  4. pmc Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
    David I Marks
    University Hospitals Bristol NHS Foundation Trust, Bristol, UK
    Br J Haematol 155:318-27. 2011
    ..Voriconazole could be given for significantly longer durations, with less need for other systemic antifungals...
  5. ncbi request reprint Haploidentical stem cell transplantation for children with acute leukaemia
    David I Marks
    BMT Unit, Bristol Children s Hospital, United Bristol Healthcare Trust, Bristol, UK
    Br J Haematol 134:196-201. 2006
    ..None of the nine patients with acute myeloid leukaemia not in remission have survived...
  6. ncbi request reprint A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission
    David I Marks
    Adult BMT Unit, Bristol Children s Hospital, Bristol, UK
    Biol Blood Marrow Transplant 12:438-53. 2006
    ..We conclude that for HLA-identical sibling allografts for acute lymphoblastic leukemia in CR2, there is an advantage in substituting etoposide for Cy or, when Cy is used, in increasing the TBI dose to > or =13 Gy...